EVH vs. PYCR, TDC, DOCN, VSH, SVFCX, HAYW, WOLF, USM, AI, and ATHM
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include Paycor HCM (PYCR), Teradata (TDC), DigitalOcean (DOCN), Vishay Intertechnology (VSH), Smead Value C (SVFCX), Hayward (HAYW), Wolfspeed (WOLF), United States Cellular (USM), C3.ai (AI), and Autohome (ATHM). These companies are all part of the "computer and technology" sector.
Evolent Health (NYSE:EVH) and Paycor HCM (NASDAQ:PYCR) are both mid-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and dividends.
Evolent Health received 510 more outperform votes than Paycor HCM when rated by MarketBeat users. Likewise, 73.88% of users gave Evolent Health an outperform vote while only 35.11% of users gave Paycor HCM an outperform vote.
36.8% of Paycor HCM shares are owned by institutional investors. 3.3% of Evolent Health shares are owned by company insiders. Comparatively, 0.9% of Paycor HCM shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Evolent Health presently has a consensus price target of $42.00, indicating a potential upside of 78.34%. Paycor HCM has a consensus price target of $24.94, indicating a potential upside of 73.18%. Given Evolent Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Evolent Health is more favorable than Paycor HCM.
Evolent Health has a net margin of -5.07% compared to Paycor HCM's net margin of -11.11%. Evolent Health's return on equity of 6.90% beat Paycor HCM's return on equity.
Paycor HCM has lower revenue, but higher earnings than Evolent Health. Paycor HCM is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.
Evolent Health has a beta of 1.57, meaning that its stock price is 57% more volatile than the S&P 500. Comparatively, Paycor HCM has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500.
In the previous week, Paycor HCM had 22 more articles in the media than Evolent Health. MarketBeat recorded 42 mentions for Paycor HCM and 20 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.36 beat Paycor HCM's score of 0.13 indicating that Evolent Health is being referred to more favorably in the media.
Summary
Evolent Health beats Paycor HCM on 13 of the 18 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
